2025 - Environmental Sustainability and the Supply of Medicines for Clinical Trials

Did you know that the healthcare sector is responsible for nearly 5 percent of global emissions, with the pharmaceutical industry being a significant contributor?
The pharma industry’s emission intensity is almost 55 percent higher than that of the automotive sector and 71 percent of those emissions come from the supply chain.
Despite a compound annual growth rate (CAGR) of around 15 percent, big pharma’s emissions are on a downward trend, showcasing their leadership in sustainability practices. The rest of the industry is following suit by measuring the baseline and setting targets that align with global ambitions.
In this webinar, the expert speaker will explore environmental sustainability as it relates to the supply of medicines for use in clinical trials and identify the key contributing factors. He will walk through the structure and categorization of emissions, how they can be measured, how targets are set and most importantly how they can be achieved.
Join this educational session where the speakers discuss how major pharma companies are working towards environmental sustainability and reducing their environmental impact.
Keywords: Clinical Trials, Clinical Research, Marketing, Sustainability, Commercial Manufacturing, Environmental Sustainability, Supply Chain/Logistics